An Analysis of Intra-Cellular Therapies Inc (ITCI)’s Potential Price Growth
Intra-Cellular Therapies Inc’s recent filing unveils that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Intra-Cellular Therapies Inc’s recent filing unveils that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies
Intra-Cellular Therapies Inc’s filing revealed that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on Sep
Intra-Cellular Therapies Inc’s recently made public that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
In a filing, Intra-Cellular Therapies Inc revealed its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Intra-Cellular Therapies Inc’s recent filing unveils that its Director ALEXANDRIA VENTURE INVESTMENTS acquired Company’s shares for reported $1.83 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Intra-Cellular Therapies
Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.